Search research articles
Contact Us
Filters
Showing results (71-80 of 608) with videos related to
Page
of 61
Sort By:
In Vivo (Athens, Greece)
|
March 31, 2017
Chemoradiation Including Paclitaxel for Locally Recurrent Muscle-invasive Bladder Cancer in Elderly Patients
Lukas Käsmann, Lisa Manig, Stefan Janssen, et al.
Anticancer Research
|
April 28, 2025
Two Scoring Tools to Estimate the Risk of Taxane-induced Peripheral Sensory Neuropathy (PNP) in Patients Irradiated for Non-metastatic Breast Cancer
Dirk Rades, Tobias Bartscht, Achim Rody, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
October 13, 2005
Late effects and cosmetic results of conventional versus hypofractionated irradiation in breast-conserving therapy
Fabian Fehlauer, Silke Tribius, Winfried Alberti, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 31, 2002
Is there a dose-effect relationship for the treatment of symptomatic vertebral hemangioma?
Dirk Rades, Amira Bajrovic, Winfried Alberti, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 3, 2004
Treatment of solitary brain metastasis. Resection followed by whole brain radiation therapy (WBRT) and a radiation boost to the metastatic site
Dirk Rades, Annette Raabe, Amira Bajrovic, et al.
Nature Reviews. Clinical Oncology
|
March 18, 2010
Treatment of painful bone metastases
Dirk Rades, Steven E Schild, Janet L Abrahm
Oncology Reports
|
March 8, 2007
The inhibition of proliferation and migration of glioma spheroids exposed to temozolomide is less than additive if combined with irradiation
Fabian Fehlauer, Martina Muench, Eckhard Richter, et al.
Lung
|
February 5, 2016
Stereotactic Body Radiotherapy (SBRT) with Lower Doses for Selected Patients with Stage I Non-small-cell Lung Cancer (NSCLC)
Stefan Janssen, Lukas Kaesmann, Volker Rudat, et al.
In Vivo (Athens, Greece)
|
February 26, 2016
Stereotactic Body Radiotherapy Provides Excellent Long-Term Local Control of Very Few Lung Metastases
Stefan Janssen, Lukas Käsmann, Volker Rudat, et al.
Anticancer Research
|
February 7, 2016
Karnosky Performance Score and Radiation Dose Predict Survival of Patients Re-irradiated for a Locoregional Recurrence of Small Cell Lung Cancer
Lukas Käsmann, Stefan Janssen, Steven E Schild, et al.
Page
of 61
Search research articles
Search
Showing results (71-80 of 608) with videos related to
Sort By:
Page
of 61
In Vivo (Athens, Greece)
|
March 31, 2017
Chemoradiation Including Paclitaxel for Locally Recurrent Muscle-invasive Bladder Cancer in Elderly Patients
Lukas Käsmann, Lisa Manig, Stefan Janssen, et al.
Anticancer Research
|
April 28, 2025
Two Scoring Tools to Estimate the Risk of Taxane-induced Peripheral Sensory Neuropathy (PNP) in Patients Irradiated for Non-metastatic Breast Cancer
Dirk Rades, Tobias Bartscht, Achim Rody, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
October 13, 2005
Late effects and cosmetic results of conventional versus hypofractionated irradiation in breast-conserving therapy
Fabian Fehlauer, Silke Tribius, Winfried Alberti, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 31, 2002
Is there a dose-effect relationship for the treatment of symptomatic vertebral hemangioma?
Dirk Rades, Amira Bajrovic, Winfried Alberti, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 3, 2004
Treatment of solitary brain metastasis. Resection followed by whole brain radiation therapy (WBRT) and a radiation boost to the metastatic site
Dirk Rades, Annette Raabe, Amira Bajrovic, et al.
Nature Reviews. Clinical Oncology
|
March 18, 2010
Treatment of painful bone metastases
Dirk Rades, Steven E Schild, Janet L Abrahm
Oncology Reports
|
March 8, 2007
The inhibition of proliferation and migration of glioma spheroids exposed to temozolomide is less than additive if combined with irradiation
Fabian Fehlauer, Martina Muench, Eckhard Richter, et al.
Lung
|
February 5, 2016
Stereotactic Body Radiotherapy (SBRT) with Lower Doses for Selected Patients with Stage I Non-small-cell Lung Cancer (NSCLC)
Stefan Janssen, Lukas Kaesmann, Volker Rudat, et al.
In Vivo (Athens, Greece)
|
February 26, 2016
Stereotactic Body Radiotherapy Provides Excellent Long-Term Local Control of Very Few Lung Metastases
Stefan Janssen, Lukas Käsmann, Volker Rudat, et al.
Anticancer Research
|
February 7, 2016
Karnosky Performance Score and Radiation Dose Predict Survival of Patients Re-irradiated for a Locoregional Recurrence of Small Cell Lung Cancer
Lukas Käsmann, Stefan Janssen, Steven E Schild, et al.
Page
of 61